Barinthus Biotherapeutics plc. Annual Return On Equity in % from 2020 to 2023

Taxonomy & unit
ratio: %
Description
Return on equity can be defined as the amount of net income returned as a percentage of shareholders equity. Return on equity measures a corporation's profitability by revealing how much profit a company generates with the money shareholders have invested.
Summary
Barinthus Biotherapeutics plc. quarterly/annual Return On Equity history and growth rate from 2020 to 2023.
  • Barinthus Biotherapeutics plc. Return On Equity for the quarter ending June 30, 2024 was -35.9 %, a 53.2% decline year-over-year.
  • Barinthus Biotherapeutics plc. annual Return On Equity for 2023 was -35.2 %, a 1739% decline from 2022.
  • Barinthus Biotherapeutics plc. annual Return On Equity for 2022 was 2.15 %.
  • Barinthus Biotherapeutics plc. annual Return On Equity for 2021 was -29.4 %, a 150% decline from 2020.
Return On Equity, Annual (%)
Return On Equity, YoY Annual Growth (%)
Period Value YoY Chg Change % Start Date End Date
2023 -35.2 -37.3 -1739% Jan 1, 2023 Dec 31, 2023
2022 2.15 +31.5 Jan 1, 2022 Dec 31, 2022
2021 -29.4 -88 -150% Jan 1, 2021 Dec 31, 2021
2020 58.6 Jan 1, 2020 Dec 31, 2020
* An asterisk sign (*) next to the value indicates that the value is likely invalid.